Kura Oncology (KURA) has released an update to notify the public and investors about the unregistered sales of equity securities.
The offering and sale of securities in the Private Placement were made relying on exemptions from registration requirements under the Securities Act of 1933 and state laws, specifically Regulation D and “blue sky” laws. The securities are unregistered and cannot be offered or sold without SEC registration or an exemption. The transaction was a non-public offering without advertising, and purchasers are accredited investors intending to hold the securities without plans for immediate resale in violation of federal securities laws.
For further insights into KURA stock, check out TipRanks’ Stock Analysis page.
